Study Shows SpotitEarly's
High Accuracy
The Rainbow Study, a large-scale observational double blind clinical performance trial, measured the effectiveness and accuracy of SpotitEarly’s breath test in detecting the 4 most common types of cancer at various stages, using breath samples.
Sensitivity
Specificity
4 Types of Cancer Targeted:
Lung, Breast, Prostate, Colorectal
3
Medical Centers
1,386
Participants
338
Cancer positives
1,048
Controls
The Rainbow Study is the first clinical performance trial of its kind, using a bio-hybrid platform powered by AI to detect cancer in breath samples. Its results show outstanding accuracy by all measures, and across cancer stages, even the earliest ones, when it really counts.
The study, led by Prof. Nadir Arber Director of the Integrated Cancer Prevention Center (ICPC) at Tel Aviv Sourasky Medical Center, was conducted at three prominent medical centers.
Clinical Partners
University
of Pennsylvania
Tel Aviv Sourasky
Medical Center
Hadassah
Medical Center
Rambam Health
Care Campus
Assuta
Hospital
Impressive Sensitivity in Early Stages 1 & 2
Clinical Study Program
The Pink Study
The Pink study is an ongoing clinical performance trial dedicated to the early detection of Breast cancer. Our researchers are actively working to develop innovative methods to detect Breast cancer at its earliest stages, where treatment options are most effective, while helping prevent unnecessary intervention and stress.
This trial is being conducted in cooperation with the University of Pennsylvania (UPenn) and the Tel- Aviv Sourasky Medical Center
Enrolling
The White Study
The White study is another ongoing clinical performance trial focused on early detection of Lung cancer. Our dedicated team of scientists and medical professionals are striving to develop advanced techniques to identify Lung cancer in its early stages, leading to improved outcomes for more patients while relieving some of the burden on healthcare systems.
SpotitEarly’s performance has demonstrated:
-
High accuracy across 4 cancer types the system was trained for, as well as in multiple others
-
Very high sensitivity and confidence level in the early stages of cancer